Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q3 2021 vs. Q2 2021
How the institutions holding Alterity Therapeutics Ltd changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 14 | 14 | 0 |
| Shares | 990.4K | 638.4K | −352.0K (−35.5%) |
| Value | $1.29M | $808.1K | −$477.0K (−37.1%) |
New holders (4)
Institutions that held Alterity Therapeutics Ltd at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 16,107 | $20.0K | 0.00% |
| Virtu Financial LLC | 11,351 | $14.0K | 0.00% |
| Providence Capital Advisors, LLC | 2,000 | $3.00K | 0.00% |
| Optimum Investment Advisors | 927 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Alterity Therapeutics Ltd at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Renaissance Technologies LLC | 237,903 | $309.0K |
| Millennium Management LLC | 36,937 | $48.0K |
| UBS Group AG | 4,658 | $6.00K |
| FMR LLC | 1 | $0 |